Menu

Clinical Pharmacology

Pharmaceutical Therapy Consultations

Indications
Dosage and dosage adjustments
Adverse drug reactions/side effects
Drug interactions
Usage during pregnancy and lactation
Composition/formulation of medications
Possible modes of application
New drugs
Bioequivalence and generic equivalents
Expiration date

Clinical Pharmacology outpatient consultation unit

Patients can visit us on an outpatient basis for the evaluation of complex drug therapies with regard to efficacy, side effects and drug interactions.

In general, this involves:

- Detailed medical history
- Special drug history (incl. "brown bag analysis")
- Physical examination
- Analysis of relevant laboratory parameters (especially drug levels in the blood).

If required:

- Additional diagnostic procedures (e.g. imaging, ultrasound, etc.)
- Consultation with colleagues from other department of the UKB

After medication analysis and evaluation of all diagnostic results, a doctor's letter is issued with assessments and recommendations regarding:

- Discontinuation/replacement of medications due to side effects or drug interactions
- Adjustment of doses
- Identification of potentially inadequate medication (PIM) in elderly patients according to Priscus and FORTA
- Integrated medication plan

We will need a referral from a physician (e.g. general practitioner, specialist) as well as an overview of the patient's medical history (if possible with current laboratory parameters) and the current medication (drug substance, dosage, times).

Participation on Rounds

For interested clinics from UKB, we offer our participation during rounds to help with:

Recognition and avoidance of drug interactions
Dosage adjustment
Systematic recording and interpretation of unwanted side effects
Suggestions for alternative therapies/drugs
Assistance for physicians in reporting side effects to the proper authorities
Information about guideline-based therapy
Pharmacoeconomic consultation

For further questions, please contact:

Dr.  med. Martin Coenen

Tel.: +49 228 287-16045
Fax: +49 228 287-16036
 

Link to the Phase I Trial Unit (in German)

 
This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.